Health

Govt Plans to Make Public Details of Patented Drugs

Move to help Indian cos challenge patent holders & sell low-cost version of high-priced drugs

The government will make public details of every medicine patented in the country to bring transparency

Publication Date: 
14/04/2011
Economic Times (New Delhi)
Tags:
Patents, Drugs, Drug Industry, India, Health Care
Health

Bio-piracy of Unani medicine at European Patent Office

Several assets of Unani medicine are available in different languages, includ-
ing Urdu, Persian and Arabic. These literary assets are easily accessible and

Publication Date: 
10/04/2011
U. Akram, M. U. Azhar, J. Akhtar & et al
Current Science
100
7
962
Tags:
Unani, Traditional Knowledge, Medical Systems, Patents, Europe, Medicinal Plants, Health
Health

Non-Compliance with Disclosure Norms on Patents May Bring Trouble for Pharma Cos

Several global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India, making them vulnerable to penalties and potentially allowing local firms to make and sell low-cost version of their drugs, local patent lawyers said.

To ensure that the patents granted in India are being utilised for the benefit of patients, companies must

Publication Date: 
07/04/2011
Economic Times (New Delhi)
Tags:
Patents, Drugs, Drug Industry, Health Care, India
Agriculture

Paan loses flavour

Read this special report by Down To Earth on the iconic Paan losing its appeal. Its trade has dipped 40-50 per cent in the past decade, while consumption of chewing tobacco, especially gutkha, increased during the period. Farmers now prefer other crops.

Publication Date: 
31/03/2011
Richard Mahapatra, Moyna, Sayantan Bera
Down to Earth
19
21
0
Tags:
Agricultural Inputs, Agriculture, Balasore (D), Cash Crops, Delhi, Exports, Farmers, Irrigation, Mahoba (D), Medicinal Plants, Minor Forest Produce, Orissa (Odisha), Patents, Traditional Knowledge, Uttar Pradesh, West Bengal, Betel Leaf
Health

Patent Expiry to Hit Bottom Lines of Drug Firms

At the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company

Publication Date: 
08/03/2011
Economic Times (New Delhi)
Tags:
Drugs, Drug Industry, Patents, Health Care, India
Health

WTO, WIPO and WHO examine role of patent information in access to medicines



The information in patent documents and applications can play an important role in improving access to

Publication Date: 
02/03/2011
Bridges Weekly Trade News Digest
15
7
0
Tags:
Health, WHO, WTO, World Intellectual Property Organization ('WIPO), Patents, Information, Intellectual Property Rights (IPR), Developing Countries, Drugs, Research
Land

To save farmers, stop land acquisition, seed patents

To save the three

Publication Date: 
11/02/2011
Indian Express (New Delhi)
Tags:
Land Acquisition, Seeds, Patents, Farmers, Displacement, Sabarmati, Ecology, Intellectual Property Rights (IPR)
Biodiversity

Biodiversity access and benefit-sharing: weaving a rope of sand

The Convention on Biological Diversity (CBD)1 is one of the most important treaties in the history of humanity as it deals with the infinitely complex but fragile diversity of life on earth. Regulating access to genetic resources and equitable sharing of commercial benefits of biodiversity has been the most contentious issue in the negotiations under CBD.

Publication Date: 
10/02/2011
Priyadarsanan Dharma Rajan, K. D. Prathapan
Current Science
100
3
290
Tags:
Biodiversity, Benefit Sharing, Biodiversity Conservation, Convention On Biological Diversity (CBD), Genetic Resources, Traditional Knowledge, Patents, Global
Science And Technology

Patenting of microorganisms in India: a point to ponder

The arguments surrounding the merits and demerits of patents shift between the right of the inventor to enjoy the fruits of his labour and his duty towards the society.

Publication Date: 
25/01/2011
Suja Senan, M. G. Haridas, J. B. Prajapati
Current Science
100
2
159
Tags:
Patents, Micro Organisms, India, GMOs, Science And Technology
Health

India: access to affordable drugs and the right to health

Nearly 2 billion people (a third of the world's population) lack access to essential medicines. In low-income and middle-income countries, drugs account for 20

Publication Date: 
12/01/2011
Anand Grover, Brian Citro
Lancet
0
0
1
Tags:
Health, India, Health Care, Health Policy, Drugs, Health For All, Drug Industry, Patents, Intellectual Property Rights (IPR), Multinational Corporations (MNCs)

Pages